These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6182888)

  • 1. Novel combination chemotherapy of experimental trypanosomiasis by using bleomycin and DL-alpha-difluoromethylornithine; reversal by polyamines.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Biochem Pharmacol; 1982 Sep; 31(17):2833-6. PubMed ID: 6182888
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism by polyamines of the curative effects of alpha-difluoromethylornithine in Trypanosoma brucei brucei infections.
    Nathan HC; Bacchi CJ; Hutner SH; Rescigno D; McCann PP; Sjoerdsma A
    Biochem Pharmacol; 1981 Nov; 30(21):3010-3. PubMed ID: 6797437
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.
    Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
    Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
    Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei.
    Demey F
    Vet Res Commun; 1987; 11(3):271-4. PubMed ID: 2442883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin-induced life prolongation of mice infected with Trypanosoma brucei brucei EATRO 110.
    Nathan HC; Bacchi CJ; Sakai TT; Rescigno D; Stumpf D; Hutner SH
    Trans R Soc Trop Med Hyg; 1981; 75(3):394-8. PubMed ID: 6172890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine metabolism: a potential therapeutic target in trypanosomes.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis.
    Bitonti AJ; Bacchi CJ; McCann PP; Sjoerdsma A
    Biochem Pharmacol; 1985 May; 34(10):1773-7. PubMed ID: 3924048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei.
    Bacchi CJ; Garofalo J; Mockenhaupt D; McCann PP; Diekema KA; Pegg AE; Nathan HC; Mullaney EA; Chunosoff L; Sjoerdsma A; Hutner SH
    Mol Biochem Parasitol; 1983 Mar; 7(3):209-25. PubMed ID: 6193423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of reuterin and its combinations with suramin, melarsoprol, DL-alpha-difluoromethylornithine and bleomycin in mice infected with Trypanosoma brucei brucei.
    Yunmbam MK; Roberts JF
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Jul; 105(3):521-4. PubMed ID: 7693393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine decarboxylase in Trypanosoma brucei brucei: evidence for selective toxicity of difluoromethylornithine.
    Garofalo J; Bacchi CJ; McLaughlin SD; Mockenhaupt D; Trueba G; Hutner SH
    J Protozool; 1982 Aug; 29(3):389-94. PubMed ID: 6813460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
    Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
    Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine.
    Sjoerdsma A; Golden JA; Schechter PJ; Barlow JL; Santi DV
    Trans Assoc Am Physicians; 1984; 97():70-9. PubMed ID: 6442954
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of antibody in the elimination of trypanosomes after DL-alpha-difluoromethylornithine chemotherapy.
    de Gee AL; McCann PP; Mansfield JM
    J Parasitol; 1983 Oct; 69(5):818-22. PubMed ID: 6423794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
    McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
    Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic implications of polyamine biosynthesis inhibition.
    Sjoerdsma A; Schechter PJ
    Clin Pharmacol Ther; 1984 Mar; 35(3):287-300. PubMed ID: 6421528
    [No Abstract]   [Full Text] [Related]  

  • 18. Curative effect of alpha-difluoromethylornithine on fatal Trypanosoma congolense infection in mice.
    Karbe E; Böttger M; McCann PP; Sjoerdsma A; Freitas EK
    Tropenmed Parasitol; 1982 Sep; 33(3):161-2. PubMed ID: 6814025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
    Breton JC; Bouteille B; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
    Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
    Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.